Literature DB >> 15981747

Is procalcitonin useful in early diagnosis of serious bacterial infections in children?

Sudhin Thayyil1, Mohan Shenoy, Mainga Hamaluba, Anil Gupta, John Frater, Ian G Verber.   

Abstract

AIM: To compare diagnostic accuracy of procalcitonin for early diagnosis of serious bacterial infection (SBI) in children presenting with fever and no focus of infection.
METHODS: Prospective, observational study involving 72 children (1-36 mo) presenting to the paediatric units of two university hospitals. All children had blood cultures, urine cultures, white blood cell counts (WBC), chest X-ray, C-reactive protein (CRP) and procalcitonin (PCT) done at presentation.
RESULTS: Eight (11.1%) children had SBI (1 pneumonia, 2 meningitis, 4 septicaemia/occult bacteraemia, 2 pyelonephritis), 19 (26.4%) had possible bacterial infection (received antibiotic treatment, but no organism grown) and 45 (62.5%) had viral or possible viral infection (virus isolated and/or uneventful recovery without antibiotics). PCT (>2 ng/l), CRP (>50 mg/l) and McCarthy's score (<9) had sensitivities and specificities of 50%/85.9%, 75%/68.7% and 87.5%/67.2%, respectively. Negative and positive likelihood ratios for CRP (>50 mg/l), PCT (>2 ng/l), white blood cells (>15 x 10(5)/l) and McCarthy's score (<9) were 0.36/2.4, 0.58/3.5, 0.94/1.1 and 0.19/2.7, respectively. A combination of PCT, CRP and WBC generated a positive likelihood ratio of 10.6, changing the post-test probability to 54%.
CONCLUSION: For early diagnosis of SBI in children presenting with fever and no focus of infection, the diagnostic utility of procalcitonin is similar to the traditional markers infection and clinical scoring. While a low procalcitonin level cannot be used to exclude SBI in this population, a combination of PCT, CRP and WBC may be more useful in predicting SBI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981747     DOI: 10.1111/j.1651-2227.2005.tb01883.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  18 in total

Review 1.  In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus?

Authors:  David Herd
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

Review 2.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

3.  Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.

Authors:  Clarissa Valim; Rushdy Ahmad; Miguel Lanaspa; Yan Tan; Sozinho Acácio; Michael A Gillette; Katherine D Almendinger; Danny A Milner; Lola Madrid; Karell Pellé; Jaroslaw Harezlak; Jacob Silterra; Pedro L Alonso; Steven A Carr; Jill P Mesirov; Dyann F Wirth; Roger C Wiegand; Quique Bassat
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

Review 4.  Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.

Authors:  Nader Shaikh; Jessica L Borrell; Josh Evron; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

5.  Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children?

Authors:  Dilshad Ahmad Khan; Aisha Rahman; Farooq Ahmad Khan
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Validation of the Feverkidstool and procalcitonin for detecting serious bacterial infections in febrile children.

Authors:  Ruud G Nijman; Yvonne Vergouwe; Henriëtte A Moll; Frank J Smit; Floor Weerkamp; Ewout W Steyerberg; Johan van der Lei; Yolanda B de Rijke; Rianne Oostenbrink
Journal:  Pediatr Res       Date:  2017-11-08       Impact factor: 3.756

7.  The Value of the "Lab-Score" Method in Identifying Febrile Infants at Risk for Serious Bacterial Infections.

Authors:  Diana Aniela Moldovan; Maria Despina Baghiu; Alina Balas; Sorana Teodora Truta
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-03-01

8.  Serum hepcidin: indication of its role as an "acute phase" marker in febrile children.

Authors:  Lydia Kossiva; Alexandra Soldatou; Dimitrios I Gourgiotis; Lamprini Stamati; Charalampos Tsentidis
Journal:  Ital J Pediatr       Date:  2013-04-25       Impact factor: 2.638

9.  Accuracy of the "traffic light" clinical decision rule for serious bacterial infections in young children with fever: a retrospective cohort study.

Authors:  Sukanya De; Gabrielle J Williams; Andrew Hayen; Petra Macaskill; Mary McCaskill; David Isaacs; Jonathan C Craig
Journal:  BMJ       Date:  2013-02-13

10.  Clinical prediction model to aid emergency doctors managing febrile children at risk of serious bacterial infections: diagnostic study.

Authors:  Ruud G Nijman; Yvonne Vergouwe; Matthew Thompson; Mirjam van Veen; Alfred H J van Meurs; Johan van der Lei; Ewout W Steyerberg; Henriette A Moll; Rianne Oostenbrink
Journal:  BMJ       Date:  2013-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.